Roberto Borea Highlight Multi-Omic Approach to NSCLC Diagnostics
Roberto Borea, Postdoctoral Research at Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, shared a post by Claudia Scimone, PHD Student at University of Naples Federico II on X, adding:
“In NSCLC, tissue and liquid biopsy are standard of care. In this review led by Claudia Scimone we outline different NGS platforms and how SNVs/indels/CNAs/fusions guide therapy. We also look ahead to multiomics analysis to reshape care.”
Quoting Claudia Scimone‘s post:
“I’m proud to share the publication of our latest review:
In this work, we explore how a multi-omic evaluation can significantly modify clinical algorithm for NSCLC patients.”
Title: Innovation in next-generation sequencing in non-small cell lung cancer diagnostics
Authors: Claudia Scimone, Lucia Palumbo, Roberto Borea, Claudia Sarracino, Ilaria Tomaiuolo, Domenica Di Giovanni, Sabrina Alfano, Mariantonia Nacchio, Gianluca Russo, Alessandro Russo, Francesco Pepe, Giancarlo Troncone, Umberto Malapelle
More posts featuring Roberto Boreaon OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023